COVID-19 vaccine (Sorrento Therapeutics)

N/A

Report date: 2024/08/29 15:32:51

Base Information

Drug NameCOVID-19 vaccine (Sorrento Therapeutics)

Drug Alias NamerS1-Fc protein(Sorrento Therapeutics)Targeted virus vaccine against COVID-19 (Sorrento Therapeutics)STI-3333T-VIVA-19

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Genetically engineered subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSorrento Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesSorrento Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A